Steatohepatitis : NASH and ASH /
| Corporate Author: | |
|---|---|
| Other Authors: | , , |
| Format: | Conference Proceeding Book |
| Language: | English |
| Published: |
Dordrecht : Boston :
Kluwer Academic,
[2001]
|
| Series: | Falk symposium ;
121. |
| Subjects: |
Table of Contents:
- Sec. I. Epidemiology, diagnosis and definition of NASH
- Epidemiology and risk factors for fatty liver
- Non-alcoholic liver disease : natural history
- Pathology and classification of non-alcoholic steatohepatitis
- Non-alcoholic steatohepatitis : grading and staging the histological lesions
- Diagnosis of non-alcoholic steatohepatitis
- Sec. II. Pathogenic mechanisms of NASH and ASH
- The genetic basis for non-alcoholic and alcoholic steatohepatitis
- Oxidative stress in alcoholic and non-alcoholic steatohepatitis
- Endotoxins and cytokines in the pathogenesis of non-alcoholic steatohepatitis
- Cyclooxygenase-2 : a potential target for the prevention and treatment of alcoholic liver disease
- Inducible cytochromes P450 and lipid peroxidation in non-alcoholic steatohepatitis
- Mitochondrial dysfunction in hepatitic steatohepatitis
- Role of iron in non-alcoholic and alcoholic steatohepatitis
- Insulin resistance in non-alcoholic fatty liver disease : a clinical perspective
- Sec. III. Aetiology of NASH and ASH
- Obesity and non-alcoholic steatohepatitis
- Non-alcoholic steatohepatitis and intestinal disease
- Drugs and non-alcoholic steatohepatitis
- Failure of regeneration of the steatotic liver : disruption at two different levels in the regeneration pathway
- Obesity and cryptogenic cirrhosis
- Diet and alcoholic steatohepatitis
- Gender and alcoholic steatohepatitis
- The intrahepatic and extrahepatic metabolic abnormalities associated with non-alcoholic steatohepatitis
- Sec. IV. Therapeutic options for NASH
- Treatment of non-alcoholic steatohepatitis : role of ursodeoxycholic acid
- Clofibrate and other lipid-lowering drugs in the treatment of non-alcoholic steatohepatitis
- Alpha-tocopherol and antioxidants in the treatment of non-alcoholic steatohepatitis
- Diet and exercise : important first steps in the therapy of non-alcoholic fatty liver disease
- Sec. V. Histopathology and clinical aspects of ASH
- Histological hallmarks of alcoholic steatohepatitis
- Alcoholic and non-alcoholic steatohepatitis : histological differences and pathogenesis of cytoskeleton alterations
- Clinical spectrum of alcoholic steatohepatitis
- Prognosis of alcoholic hepatitis
- Carbohydrate-deficient transferrin : clinical value and pitfalls
- Sec. VI. Alcohol and cytotoxicity
- Alcohol and mitochondrial function
- Role of bile acids blocking ethanol-induced apoptosis
- Interactions of alcohol, steatosis and hepatitis C
- Sec. VII. Management of alcoholic hepatitis
- Metabolic and nutritional interventions in the treatment of alcoholic hepatitis
- Alcoholic hepatitis steroid yes?
- Alcoholic hepatitis : no glucocorticosteroids?
- Beneficial effects of polyenylphosphatidylcholine in alcoholic and non-alcoholic liver injury
- S-adenosylmethionine in alcoholic liver disease